Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals

Human Genetics

Volumn 102, Issue 4, 1998, Pages 397-402

  Iwama, Hiroshi ^a   Ohyashiki, Kazuma ^a   Ohyashiki, Junko H ^a   Hayashi, Shigifumi ^a   Yahata, Naoyuki ^a   Ando, Keiko ^a   Toyama, Keisuke ^a   Hoshika, Akinori ^a   Takasaki, Masaru ^a   Mori, Mayumi ^b   Shay, Jerry W ^c  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology   (Japan)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TELOMERASE;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BLOOD CELL; CHILD; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME ASSAY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT; SOUTHERN BLOTTING; TELOMERE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CHILD; CHILD, PRESCHOOL; ENZYME ACTIVATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; TELOMERASE; TELOMERE;

EID: 0031922795     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050711     Document Type: Article

References (40)

1. Adamson DJA, King DJ, Haites NE (1992) Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 61:204-206
2. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89:10114-10118
3. Broccoli D, Young JW, Lange T de (1995) Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 92:9082-9086
4. Chiu CP, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, Harley CB, Lansdorp PM (1996) Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cell 14:239-248
5. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Grider CW, Harley CB, Bacchetti S (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11:1921-1929
6. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S (1995) Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85:2315-2320
7. Harle-Bachor C, Boukamp P (1996) Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93:6476-6481
8. Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during aging of human fibroblasts. Nature 345:458-460
9. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC (1990) Telomere reduction in human colorectal carcinoma and with aging. Nature 346:866-868
10. Hiyama K, Hirai Y, Koizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M (1995) Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155:3711-3715
11. Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, Yokoyama T (1996) Telomerase activity in human intestine. Int J Oncol 9:453-458
12. Holt SE, Shay JW, Wright WE (1996) Refining the telomere-telomerase hypothesis of aging and cancer. Nature Biotechnol 14:836-839
13. Hsiao R, Sharma HW, Ramakrishnan S, Keith E, Narayanan R (1997) Telomerase activity in normal human endothelial cells. Anticancer Res 17:827-832
14. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015
15. Kyo S, Takakura M, Kohama T, Inoue M (1997) Telomerase activity in human endometrium. Cancer Res 57:610-614
16. Lange T de (1995) Telomere dynamics and genome instability in human cancer. In: Blackburn EH, Greider CW (eds) Telomeres. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp 265-293
17. Lange T de, Shiue L, Myers RM, Cox DR, Naylor SL, Killey AM, Varmus HE (1990) Structure and variability of human chromosome ends. Mol Cell Biol 10:518-527
18. Lindsey J, Mcgill NI, Lindsey LA, Green DK, Cooke HJ (1991) In vivo loss of telomeric repeats with age in humans. Mutat Res 256:45-48
19. n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85:6622-6626
20. Norrback K-F, Dahlenborg K, Carlsson R, Ross G (1996) Telomerase activity in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 88:222-229
21. Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A, Toyama K (1994) Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 54:3557-3560
22. Ohyashiki JH, Ohyashiki K, Sano T, Toyama K (1996a) Non-radioisotopic and semi-quantiative procedure for terminal repeat amplification protocol. Jpn J Cancer Res 87:329-331
23. Ohyashiki JH, Ohyashiki K, Toyama K, Shay JW (1996b) A non-radioactive, fluorescence-based telomeric repeat amplification protocol to detect and quantitate telomerase activity. Trends Genet 12:395-396
24. Ohyashiki JH, Ohyashiki K, Iwama H, Hayashi S, Toyama K, Shay JW (1997a) Clinical implications of telomerase activity levels in acute leukemia. Clin Cancer Res 3:619-625
25. Ohyashiki K, Ohyashiki JH, Nishimaki J, Toyama K, Ebihara Y, Kato H, Wright WE, Shay JW (1997b) Cytologic detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 57:2100-2103
26. Pan C, Xue B-H, Ellis TM, Peace DJ, Diaz MO (1997) Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp Cell Res 231:346-353
27. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, Shay JW (1995) Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17:1-15
28. Ramirez RD, Wright WE, Shay JW, Taylor RS (1997) Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 108:113-117
29. Saito T, Schneider A, Martel N, Mizumoto H, Bulgay-Moerschel M, Kudo R, Nakazawa H (1997) Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis. Biochem Biophys Res Commun 231:610-614
30. Satoh H, Hiyama K, Takeda M, Awaya Y, Watanabe K, Ihara Y, Maeda H, Ishioka S, Yamakido M (1996) Telomere shortening in peripheral blood cells was related with aging but not with white blood cell count. Jpn J Hum Genet 41:413-417
31. Shay JW (1995) Aging and cancer: are telomeres and telomerase the connection? Mol Med Today 1:378-384
32. Shay JW, Wright WE (1996) Telomerase activity in human cancer. Curr Opin Oncol 8:66-71
33. Shay JW, Werbin H, Wright WE (1996) Telomeres and telomerase in human leukemias. Leukemia 10:1255-1261
34. Takauchi K, Tashiro S, Ohtaki M, Kamada N (1994) Telomere reduction of specific chromosome translocation in acute myelocytic leukemia. Jpn J Cancer Res 85:127-130
35. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW (1996) Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 106:759-765
36. Tsao J, Zhao Y, Lukas J, Yang X, Shah A, Press M, Shibata D (1997) Telomerase activity in normal and neoplastic breast. Clin Cancer Res 3:627-631
37. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857-9860
38. Wright WE, Shay JW, Piatyszek MA (1995) Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23:3794-3795
39. Yamada O, Oshimi K, Motoji T, Mizoguchi H (1995) Telomeric DNA in normal and leukemic blood cells. J Clin Invest 95:1117-1123
40. Zhang W, Piatyszek MA, Kobayashi T, Estey E, Andreeff M, Deisseroth AB, Wright WE, Shay JW (1996) Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 2:799-803